arrow
K

Kim Hørslev-Petersen

department of regional health research
H指数:48
被引数:8,225

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cannabidiol for chronic pain in rheumatoid arthritis and ankylosing spondylitis: a randomized, placebo-controlled trial with exploratory tetrahydrocannabinol add-on

大麻二酚治疗类风湿关节炎和强直性脊柱炎慢性疼痛:一项随机、安慰剂对照试验,并探索性添加四氢大麻酚

2026-08-310
OA
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis

口服糖皮质激素联合甲氨蝶呤或关节内注射联合三联疗法在早期类风湿关节炎中的flare风险

2026-04-060
OAAI
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial

Certolizumab pegol、abatacept、tocilizumab或早期类风湿关节炎的活性常规疗法:NORD-STAR试验的48周患者报告结局

2026-03-230
PRE
Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort

更正:早期类风湿关节炎的疾病活动度和治疗反应:NORD-STAR队列的一项探索性代谢组学分析

2025-10-030
OA
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint

酰基肉碱富集作为类风湿关节炎成纤维样滑膜细胞代谢指纹的特征

2025-08-190
OAAI
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis

可溶性免疫检查点分子PD1和4-1BB与早期类风湿关节炎CTLA-4Ig治疗反应的关联

2025-07-070
OAAI
THE ASSOCIATION BETWEEN DIFFERENT ARTICULAR MANIFESTATIONS REPORTED BY PATIENTS OR RECORDED AT CLINICAL EXAMINATION AND MAGNETIC RESONANCE IMAGING- INFLAMMATION IN HANDS OF RHEUMATOID ARTHRITIS PATIENTS AT SELF-REPORTED FLARES

不同关节表现(由患者报告或临床检查记录)与类风湿关节炎患者在自我报告的疾病活动期时的手部磁共振成像炎症之间的关联

2024-06-010
PRE
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial
2024-01-182
OAAI
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naive Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts

Galectin-9水平升高与DMARD初治类风湿性关节炎患者的疾病活动相关,并调节滑膜成纤维细胞MCP-1和IL-6的分泌

CELLS
IF5.2
2023-01-153
OAAI
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
2022-10-015
OAAI
Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial
2021-01-027
PREAI
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
2020-12-0271
OAAI
Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study

疼痛和自我报告的关节肿胀是类风湿关节炎患者报告的耀斑的主要驱动因素: 一项为期12个月的观察性研究的结果

2019-12-0113
OAAI
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis The IMAGINE-RA Randomized Clinical Trial
2019-02-0569
OAAI
The D-vitamin metabolite 1,25(OH)2D in serum is associated with disease activity and Anti-Citrullinated Protein Antibodies in active and treatment naive, early Rheumatoid Arthritis Patients

血清中的D-维生素代谢物1,25(OH)2D与活动性和未治疗的早期类风湿关节炎患者的疾病活动和抗瓜氨酸化蛋白抗体相关

2018-08-2217
OAAI
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity
2017-11-0126
OAAI